葡聚糖木炭吸附法测定多肽类候选药物的血浆蛋白结合率
Determination of plasma protein binding of peptide drug candidates by dextran-coated charcoal
-
摘要: 由于某些多肽类药物在半透膜上具有非特异性吸附或者在血浆中的稳定性较差，在测定其蛋白结合率时不能适用于经典的平衡透析法和超滤法。运用葡聚糖木炭吸附法结合液质联用技术，基于候选药物吸附至葡聚糖木炭的初始速率动力学原理，选择7条具有相同氨基酸序列、不同构型的磷酸化六肽为研究模型肽，测定了其在大鼠血浆中的蛋白结合率，总结了影响多肽候选药物蛋白结合率变化的氨基酸位点规律。研究结果表明，葡聚糖木炭吸附法作为一种血浆蛋白结合率测定的补充方法，适用于传统实验技术无法测定的多肽或者有机候选药物。Abstract: The conventional equilibrium dialysis and ultrafiltration methods cannot be used to determine the protein binding of some peptides because of their non-specific adsorption on the semipermeable membrane or poor stability in the plasma. The method of dextran-coated charcoal adsorption combined with LC-MS/MS were used. Based on the kinetic principle of initial rate of candidate drugs absorbed to dextran-coated charcoal, seven phosphorylated peptides with the same amino acid sequence and different configurations in rat plasma were selected as the study model using; the protein binding in rat plasma were determined; the amino acid distribution rules affecting the changes in protein binding rates of peptide candidate drugs were summarized. The results suggest that the dextran charcoal adsorption method, as a supplementary method for the determination of plasma protein binding, is suitable for peptides or organic drug candidates that cannot be determined by traditional techniques.
-
-
[1] . Drug Discovery Today， 2012， 17（9/10）： 475-485. [2] Trainor GL. The importance of plasma protein binding in drug discovery ［J］. Expert Opin Drug Discovery， 2007， 2（1）： 51-64. [3] Yuan JH， Yang DC， Birkmeier J， et al. Determination of protein-binding by in-vitro charcoal adsorption ［J］. J Pharmacokinet Biopharm， 1995， 23（1）： 41-55. [4] Khurana M， Paliwal JK， Kamboj VP， et al. Binding of centchroman with human serum as determined by charcoal adsorption method ［J］. Int J Pharm， 1999， 192（2）： 109-114. [5] Berezhkovskiy LM. Determination of drug binding to plasma proteins using competitive equilibrium binding to dextran-coated charcoal ［J］. J Pharmacokinet Pharmacodyn， 2006， 33（5）：595-608. [6] Wenlock MC， Barton P， Austin RP. A kinetic method for the determination of plasma protein binding of compounds unstable in plasma：specific application to enalapril ［J］. J Pharm Biomed Anal， 2011， 55（3）： 385-390. [7] Puttrevu SK， Laxman TS， Tripathi AK， et al. Liquid chromatography-tandem mass spectrometry based method development and validation of S016-1271（LR8P）， a novel cationic antimicrobial peptide for its application to pharmacokinetic studies ［J］. J Pharm Biomed Anal， 2019， 169： 116-126. [8] Ollivaux C， Soyez D， Toullec JY. Biogenesis of D-amino acid containing peptides/proteins： where， when and how［J］？ J Pept Sci， 2014， 20（8）： 595-612. -
期刊类型引用(7)
1. 陈淼，李亚欣，苏安宇，王敏纯，吴颖，袁秋虹，张盼盼，王利胜. 氯诺昔康可溶性微针的制备及对类风湿性关节炎的药效学研究. 中国医院药学杂志. 2024(03): 287-294 . 
百度学术
2. 王荣倩，刘畅，王梅. 甲氨蝶呤、硫酸羟氯喹联合塞来昔布治疗对类风湿性关节炎患者免疫功能及骨代谢的影响. 系统医学. 2024(13): 188-191 . 百度学术
3. 张广辉，魏琴，李坤，苏利云，阮文思. 基于TLR4/NF-κB信号通路探究马钱子提取物对类风湿关节炎大鼠的干预效果. 中国老年学杂志. 2024(19): 4763-4767 . 百度学术
4. 戴文玲，张金玲，黎海冰. 来氟米特联合塞来昔布治疗类风湿关节炎的临床研究. 中国处方药. 2024(09): 102-105 . 百度学术
5. 范文娟，杨森，张旭升. 超声引导下关节腔药物注射治疗类风湿性关节炎的效果分析. 世界复合医学(中英文). 2024(09): 132-134+139 . 百度学术
6. 齐潇蕾，徐连那，李旭艳. 塞来昔布与依托考昔治疗类风湿关节炎临床疗效分析. 实用医院临床杂志. 2023(04): 119-122 . 百度学术
7. 刘冰，刘建瑞，孙敬波，袁红亮，汪洪波，韩冰. 雷公藤多苷片联合塞来昔布治疗活动期湿热痹阻证类风湿性关节炎临床疗效观察. 湖北中医药大学学报. 2022(05): 104-106 . 百度学术
其他类型引用(2)
计量
- 文章访问数: 246
- HTML全文浏览量: 11
- PDF下载量: 605
- 被引次数: 9
下载:
